𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Palliative treatment of neuroendocrine tumors

✍ Scribed by Dr. J. Gregory McKinnon

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
704 KB
Volume
9
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis

Effective palliation of patients with incurable neuroendocrine tumors requires both control of hormonal overproduction symptoms as well as control of tumor growth. Several important advances have been made in recent years toward these two goals. Octreotide and omeprazole have both been extremely effective in ameliorating hormonal symptoms of carcinoids, islet cell tumors and medullary thyroid carcinoma. Newer cytotoxic chemotherapy regimens and interferon have increased response rates over traditional therapy. More aggressive surgical extirpation of metastatic disease has also been beneficial.

πŸ“œ SIMILAR VOLUMES

The treatment of undifferentiated neuroe
The treatment of undifferentiated neuroendocrine tumors
✍ Emmanuel Mitry; Philippe Rougier πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 62 KB

The aggressiveness of poorly-differentiated neuroendocrine tumors is similar to small-cell lung cancer within a median survival of 6 months without treatment. Most patients have metastatic disease and poor condition at the time of diagnosis, and cannot be approached surgically with curative intent.

Palliative treatment of extrahepatic bil
Palliative treatment of extrahepatic bile ducts tumors
✍ Dr. Giuseppe Cucchiara; Giovanni Gandini; Giovanni Simonetti; Francesco Bracci; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 430 KB

Extrahepatic bile duct (EHBD) tumors often become symptomatic in an advanced stage when curative resection is seldom possible. In a group of 111 patients, 7 (6.3%) received no treatment, 32 (28.8%) underwent non-operative biliary drainage (NOD), and 72 (64.8%) underwent surgical exploration. Radical